Staphylococcus aureus immune globulin - Inhibitex

Drug Profile

Staphylococcus aureus immune globulin - Inhibitex

Alternative Names: SA-IGIV

Latest Information Update: 28 Jul 2004

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Inhibitex
  • Class Antibacterials; Immunoglobulins; Polyclonal antibodies
  • Mechanism of Action Cell adhesion molecule inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Staphylococcal infections

Most Recent Events

  • 28 Jul 2004 Discontinued - Phase-II for Staphylococcal infections in USA (unspecified route)
  • 18 Oct 2002 No development reported - Phase-II for Staphylococcal infections in USA (unspecified route)
  • 13 Apr 2000 Phase-II clinical trials for Staphylococcal infections in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top